Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keyser, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keyser, J. D.
NEUROLOGY 1988;38:371
© 1988 American Academy of Neurology

Autoimmunity in multiple sclerosis

Jacques De Keyser, MD

From the Department of Neurology, National Hospital for Nervous Diseases, London, UK.

Multiple sclerosis reportedly coexists with disorders of autoimmune origin. The prevalence with which such disorders occur in the MS population has not been adequately investigated. We reviewed the medical records of 828 patients with definite MS and found that 4. 8% had a past or present associated disorder in which autoimmune mechanisms presumably play a role. The cumulative prevalence of these disorders was no higher than that estimated for the general population. Serum from 105 patients, without clinical evidence of an associated autoimmune disorder, was tested for the presence of antinuclear, thyroid, parietal cell, smooth muscle, and mitochondrial antibodies. A significantly higher prevalence (p < 0. 01) of generally low titers of one or more autoantibodies was found in serum from the MS group, compared with a control group of 105 patients with other neurologic disorders. The increased frequency of serum autoantibodies probably reflects the existence of a nonspecific B cell overactivity in MS.

Address correspondence and reprint requests to Dr. De Keyser, Department of Neurology, Akademisch Ziekenhuis, Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.

Supported by the British Council.

Received April 22, 1987. Accepted for publication in final form July 2, 1987.




This article has been cited by other articles:


Home page
 Mult SclerHome page
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer
Comorbidity, socioeconomic status and multiple sclerosis
Multiple Sclerosis, September 1, 2008; 14(8): 1091 - 1098.
[Abstract] [PDF]

Home page
 Mult SclerHome page
N. Nielsen, M Frisch, K Rostgaard, J Wohlfahrt, H Hjalgrim, N Koch-Henriksen, M Melbye, and T Westergaard
Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark
Multiple Sclerosis, July 1, 2008; 14(6): 823 - 829.
[Abstract] [PDF]

Home page
 Mult SclerHome page
N. Garg, B. Weinstock-Guttman, K. Bhasi, J. Locke, and M. Ramanathan
An association between autoreactive antibodies and anti-interferon-{beta} antibodies in multiple sclerosis
Multiple Sclerosis, August 1, 2007; 13(7): 895 - 899.
[Abstract] [PDF]

Home page
 NeurologyHome page
C. H. Polman, L. Kappos, F. Dahlke, R. Graf, K. Beckmann, T. Bogumil, C. Pozzilli, A. J. Thompson, and the European Study Group on Interferon Beta-1b in
Interferon beta-1b treatment does not induce autoantibodies
Neurology, March 22, 2005; 64(6): 996 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
O Heinzlef, B Weill, C Johanet, V Sazdovitch, S Caillat-Zucman, E Tournier-Lasserve, and E Roullet
Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics
J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 647 - 649.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. Durelli, B. Ferrero, A. Oggero, E. Verdun, A. Ghezzi, E. Montanari, and M. Zaffaroni
Liver and thyroid function and autoimmunity during interferon-{beta}1b treatment for MS
Neurology, October 23, 2001; 57(8): 1363 - 1370.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Durelli, B. Ferrero, A. Oggero, E. Verdun, A. Ghezzi, E. Montanari, and M. Zaffaroni
Thyroid Function and Autoimmunity during Interferon {beta}-1b Treatment: A Multicenter Prospective Study
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3525 - 3532.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. A. Broadley, J. Deans, S. J. Sawcer, D. Clayton, and D. A. S. Compston
Autoimmune disease in first-degree relatives of patients with multiple sclerosis: A UK survey
Brain, June 1, 2000; 123(6): 1102 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Spadaro, M A Amendolea, M G Mazzucconi, R Fantozzi, R Di Lello, P Zangari, and C Masala
Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies
Multiple Sclerosis, April 1, 1999; 5(2): 121 - 125.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
A. Tourbah, A. Clapin, O. Gout, B. Fontaine, R. Liblau, F. Batteux, J.-L. Stievenart, B. Weill, C. Lubetzki, and O. Lyon-Caen
Systemic Autoimmune Features and Multiple Sclerosis: A 5-Year Follow-up Study
Arch Neurol, April 1, 1998; 55(4): 517 - 521.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.